
Ultilab is a franchise brand in the Healthcare Products sector in India, established in 1953 and franchising since 2021. A new unit needs an investment of ₹10L - 20L and 300 - 400 sq ft of space. It has less than 10 outlets and is headquartered in Kolkata, West Bengal. The brand is expanding in Arunachal Pradesh, Assam and Manipur and 7 more locations.
Ultilab is a newer division of United Laboratories India, a Kolkata-based pharmaceutical company formed in 1953 and acquired by the BM Group in 2013. It offers generic medicines and nutraceutical products and began franchising in 2021, focused on eastern India. The brand states an investment of ₹10 lakh to ₹20 lakh, a franchise fee of ₹3 lakh and a royalty of 0%.
Ultilab is a division of United Laboratories India, a company formed in 1953 as a private limited company and acquired by the BM Group in 2013. It is headquartered in Kolkata, West Bengal. The company says Ultilab offers a portfolio of formulations and nutraceutical products for conditions affecting men, women and children, with a stress on generic medicines.
According to the company, all formulations are made in its own production units in Bengal and Himachal Pradesh, under quality standards and certifications that include WHO norms, GLP, GMP and ISO 9001:2015. It also states that some of its products are listed in medical publications such as CIMS, Drugs Today and IDR. Its products are aimed at general physicians rather than specialists.
The brand states a total investment of ₹10 lakh to ₹20 lakh and a franchise fee of ₹3 lakh. The royalty is listed as 0%. The brand does not separately confirm that no ongoing charge applies, so check how it earns from the arrangement, such as through margins on supplied products, and whether there are minimum purchase targets.
The brand estimates a payback of one year and an expected ROI of 37%. These are the brand's own estimates and not guaranteed returns. In a pharma distribution business, results depend heavily on doctor and pharmacy relationships in your territory.
The format is a single unit in 300-400 sq ft of commercial space. The brand's focus is the east, in phases up to about 500 km from Kolkata. States it lists include West Bengal, Odisha, Assam, Sikkim, Tripura, Manipur, Meghalaya, Mizoram, Nagaland and Arunachal Pradesh. An exclusive territory is offered. Fewer than 10 units are running.
The brand says it supports franchisees with product development, training and marketing through digital, print and email campaigns. It mentions existing hospital and doctor tie-ups, and existing distributors with a medical representative network. It states that it gives no in-store branding support. Opening support, an operating manual, field assistance and IT systems are listed, with training at the corporate office.
This is a fit for someone with pharmaceutical sales or distribution experience, or an existing network of doctors and chemists in eastern India. It is a product-distribution business more than a retail shop, so success depends on selling to prescribers and pharmacies. It is not suited to someone with no healthcare contacts.
| Total investment | ₹10L - 20L |
|---|---|
| Unit franchise investment | ₹10L - 20L |
| Franchise fee | ₹3L |
| Royalty fee | 0% |
| Payback period | 1 year |
| Expected ROI | 37% |
| Space required | 300 - 400 sq ft |
| Property types | Commercial |
| Preferred locations | EAST REGION |
| Agreement term | 5 years (renewable) |
| Exclusive territory | Yes |
| Training provided | Yes |
|---|---|
| Training location | Corporate office |
| Operating manual | Yes |
| Field assistance | Yes |
| IT support | Yes |
| Opportunity type | Franchise |
|---|---|
| Franchise model | Unit |
| Headquarter | Kolkata, West Bengal |
| Established | 1953 |
| Franchising since | 2021 |
| Franchise outlets | Less than 10 |
An Ultilab franchise needs an investment of ₹10 lakh to ₹20 lakh, according to the brand, including a franchise fee of ₹3 lakh.
Ultilab lists a royalty of 0%. Ask the brand how it earns from franchisees, for example through product margins or purchase targets.
An Ultilab unit needs 300 to 400 sq ft of commercial space.
Ultilab estimates a payback of one year and an expected ROI of 37%. These are the brand's own estimates and not guaranteed.
Ultilab sells generic medicines and nutraceutical products for men, women and children, made by its parent United Laboratories India.
Ultilab is a division of United Laboratories India, which was formed in 1953 and acquired by the BM Group in 2013. It is based in Kolkata.
Ultilab is focused on eastern India, including West Bengal, Odisha, Assam and the north-eastern states, in phases up to about 500 km from Kolkata.
Ultilab states it provides training, product development support and digital, print and email marketing, but no in-store branding.
Ultilab lists a franchise agreement of 5 years, renewable.
Last updated . Information is compiled from public sources and brand submissions and may change — verify the details with Ultilab before investing.


